Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
Open Access
- 29 June 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1187937
Abstract
Drug reaction with eosinophilia and systemic symptoms or drug-induced hypersensitivity syndrome (DRESS/DIHS) is one type of severe cutaneous adverse reaction (SCAR). It is featured by fever, widespread skin lesions, protracted clinical course, internal organ involvement, and possibly long-term autoimmune sequelae. The presence of high-risk human leukocyte antigen (HLA) alleles, hypersensitivity reaction after culprit drug ingestion, and human herpesvirus reactivation may all contribute to its complex clinical manifestations. Some recent studies focusing on the roles of involved cytokines/chemokines and T cells co-signaling pathways in DRESS/DIHS were conducted. In addition, some predictors of disease severity and prognosis were also reported. In this review, we provided an update on the current understanding of the pathogenesis, potential biomarkers, and the relevant therapeutic rationales of DRESS/DIHS.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan
- Chang Gung Memorial Hospital
This publication has 208 references indexed in Scilit:
- CD134 is a cellular receptor specific for human herpesvirus-6B entryProceedings of the National Academy of Sciences, 2013
- Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected PopulationClinical Infectious Diseases, 2013
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab NetworkPLOS ONE, 2013
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireProceedings of the National Academy of Sciences, 2012
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in EuropeansNew England Journal of Medicine, 2011
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndromeJournal of the American Academy of Dermatology, 2006
- Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactionsPharmacogenetics and Genomics, 2006
- Gene map of the extended human MHCNature Reviews Genetics, 2004
- Association Between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and HypogammaglobulinemiaArchives of Dermatology, 2004